China Traditional Chinese Medicine Holdings Co. Limited (HKG:0570)
Hong Kong
· Delayed Price · Currency is HKD 1.700
+0.030 (1.80%)
Apr 29, 2026, 4:08 PM HKT
HKG:0570 Revenue
In the year 2025, China Traditional Chinese Medicine Holdings Co. had annual revenue of 14.74B CNY, down -10.69%. China Traditional Chinese Medicine Holdings Co. had revenue of 7.28B in the half year ending December 31, 2025, a decrease of -17.43%.
Revenue
14.74B CNY
Revenue Growth
-10.69%
P/S Ratio
0.51
Revenue / Employee
993.18K CNY
Employees
14,846
Market Cap
8.41B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.74B | -1.76B | -10.69% |
| Dec 31, 2024 | 16.51B | -1.61B | -8.90% |
| Dec 31, 2023 | 18.12B | 3.82B | 26.69% |
| Dec 31, 2022 | 14.30B | -4.75B | -24.92% |
| Dec 31, 2021 | 19.05B | 4.25B | 28.68% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shandong Xinhua Pharmaceutical Company | 9.74B |
| China Shineway Pharmaceutical Group | 3.49B |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical | 763.16M |
| Luye Pharma Group | 7.02B |
| SSY Group | 4.17B |
| Edding Genor Group Holdings | 2.77B |
| Ab&B Bio-Tech CO., LTD. JS | 354.77M |
| Sihuan Pharmaceutical Holdings Group | 2.91B |